{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T21:53:54Z","timestamp":1790978034282,"version":"4.1.0"},"reference-count":122,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000265","name":"UKRI Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Neurology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/s1474-4422(25)00451-x","type":"journal-article","created":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T00:04:49Z","timestamp":1769040289000},"page":"181-194","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Genetic causes and modifiers of prion diseases"],"prefix":"10.1016","volume":"25","author":[{"given":"Simon","family":"Mead","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Hermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tze How","family":"Mok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piero","family":"Parchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inga","family":"Zerr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S1474-4422(25)00451-X_bib1","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/2151043a0","article-title":"Self-replication and scrapie","volume":"215","author":"Griffith","year":"1967","journal-title":"Nature"},{"key":"10.1016\/S1474-4422(25)00451-X_bib2","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1126\/science.6801762","article-title":"Novel proteinaceous infectious particles cause scrapie","volume":"216","author":"Prusiner","year":"1982","journal-title":"Science"},{"key":"10.1016\/S1474-4422(25)00451-X_bib3","doi-asserted-by":"crossref","first-page":"4540","DOI":"10.1016\/j.molcel.2021.08.011","article-title":"High-resolution structure and strain comparison of infectious mammalian prions","volume":"81","author":"Kraus","year":"2021","journal-title":"Mol Cell"},{"key":"10.1016\/S1474-4422(25)00451-X_bib4","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-30457-7","article-title":"2\u00b77\u2008\u00c5 cryo-EM structure of ex vivo RML prion fibrils","volume":"13","author":"Manka","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/S1474-4422(25)00451-X_bib5","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/s41589-022-01229-7","article-title":"A structural basis for prion strain diversity","volume":"19","author":"Manka","year":"2023","journal-title":"Nat Chem Biol"},{"key":"10.1016\/S1474-4422(25)00451-X_bib6","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0140-6736(89)91713-3","article-title":"Insertion in prion protein gene in familial Creutzfeldt\u2013Jakob disease","volume":"1","author":"Owen","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/S1474-4422(25)00451-X_bib7","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/338342a0","article-title":"Linkage of a prion protein missense variant to Gerstmann\u2013Str\u00e4ussler syndrome","volume":"338","author":"Hsiao","year":"1989","journal-title":"Nature"},{"key":"10.1016\/S1474-4422(25)00451-X_bib8","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/epd2.20028","article-title":"Bilateral tonic-clonic seizure and focal cortical hyperexcitability in familial Creutzfeldt\u2013Jakob disease with E200K mutation of the prion protein","volume":"25","author":"Kawaguchi","year":"2023","journal-title":"Epileptic Disord"},{"key":"10.1016\/S1474-4422(25)00451-X_bib9","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.ajhg.2014.09.003","article-title":"Ascertainment bias causes false signal of anticipation in genetic prion disease","volume":"95","author":"Minikel","year":"2014","journal-title":"Am J Hum Genet"},{"key":"10.1016\/S1474-4422(25)00451-X_bib10","doi-asserted-by":"crossref","first-page":"435","DOI":"10.3390\/pathogens10040435","article-title":"Genetic risk factors of Creutzfeldt\u2013Jakob disease in the population of newborns in Slovakia","volume":"10","author":"Kosorinova","year":"2021","journal-title":"Pathogens"},{"key":"10.1016\/S1474-4422(25)00451-X_bib11","article-title":"Mortality of individuals with antemortem genetic testing for PRNP variants in the United States, 1998-2024","author":"Lian","year":"2025","journal-title":"medRxiv"},{"key":"10.1016\/S1474-4422(25)00451-X_bib12","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00401-010-0713-y","article-title":"Genetic Creutzfeldt\u2013Jakob disease associated with the E200K mutation: characterization of a complex proteinopathy","volume":"121","author":"Kovacs","year":"2011","journal-title":"Acta Neuropathol"},{"key":"10.1016\/S1474-4422(25)00451-X_bib13","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s40478-019-0706-6","article-title":"The characterization of AD\/PART co-pathology in CJD suggests independent pathogenic mechanisms and no cross-seeding between misfolded A\u03b2 and prion proteins","volume":"7","author":"Rossi","year":"2019","journal-title":"Acta Neuropathol Commun"},{"key":"10.1016\/S1474-4422(25)00451-X_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2024.106497","article-title":"Genetic and pathological features encipher the phenotypic heterogeneity of Gerstmann\u2013Str\u00e4ussler\u2013Scheinker disease","volume":"195","author":"Chen","year":"2024","journal-title":"Neurobiol Dis"},{"key":"10.1016\/S1474-4422(25)00451-X_bib15","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1093\/brain\/awy358","article-title":"Early neurophysiological biomarkers and spinal cord pathology in inherited prion disease","volume":"142","author":"Rudge","year":"2019","journal-title":"Brain"},{"key":"10.1016\/S1474-4422(25)00451-X_bib16","doi-asserted-by":"crossref","first-page":"4253","DOI":"10.1007\/s00415-022-11051-9","article-title":"Description of the first Spanish case of Gerstmann\u2013Str\u00e4ussler\u2013Scheinker disease with A117V variant: clinical, histopathological and biochemical characterization","volume":"269","author":"Era\u00f1a","year":"2022","journal-title":"J Neurol"},{"key":"10.1016\/S1474-4422(25)00451-X_bib17","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/ng0492-68","article-title":"Mutant prion proteins in Gerstmann\u2013Str\u00e4ussler\u2013Scheinker disease with neurofibrillary tangles","volume":"1","author":"Hsiao","year":"1992","journal-title":"Nat Genet"},{"key":"10.1016\/S1474-4422(25)00451-X_bib18","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1111\/ene.15676","article-title":"Clinical profiles and ethnic heterogeneity of sporadic fatal insomnia","volume":"30","author":"Chen","year":"2023","journal-title":"Eur J Neurol"},{"key":"10.1016\/S1474-4422(25)00451-X_bib19","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1136\/jnnp-2021-327247","article-title":"Clinical profile of fatal familial insomnia: phenotypic variation in 129 polymorphisms and geographical regions","volume":"93","author":"Zhang","year":"2022","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/S1474-4422(25)00451-X_bib20","doi-asserted-by":"crossref","DOI":"10.1093\/sleep\/zsac294","article-title":"Dysfunction of the cardiac parasympathetic system in fatal familial insomnia: a heart rate variability study","volume":"46","author":"Cui","year":"2023","journal-title":"Sleep"},{"key":"10.1016\/S1474-4422(25)00451-X_bib21","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1002\/ana.26008","article-title":"Neuro-ophthalmological findings in early fatal familial insomnia","volume":"89","author":"Mastrangelo","year":"2021","journal-title":"Ann Neurol"},{"key":"10.1016\/S1474-4422(25)00451-X_bib22","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1080\/19336896.2021.1968291","article-title":"Genetic Creutzfeldt\u2013Jakob disease shows fatal family insomnia phenotype","volume":"15","author":"Chen","year":"2021","journal-title":"Prion"},{"key":"10.1016\/S1474-4422(25)00451-X_bib23","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.autneu.2019.02.007","article-title":"Fatal familial insomnia and Agrypnia Excitata: autonomic dysfunctions and pathophysiological implications","volume":"218","author":"Baldelli","year":"2019","journal-title":"Auton Neurosci"},{"key":"10.1016\/S1474-4422(25)00451-X_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/v13091794","article-title":"Characterization of prion disease associated with a two-octapeptide repeat insertion","volume":"13","author":"Brennecke","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/S1474-4422(25)00451-X_bib25","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s00415-023-11968-9","article-title":"Pooled analysis of patients with inherited prion disease caused by two- to twelve-octapeptide repeat insertions in the prion protein gene (PRNP)","volume":"271","author":"Van den Broecke","year":"2024","journal-title":"J Neurol"},{"key":"10.1016\/S1474-4422(25)00451-X_bib26","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1080\/01677063.2024.2440395","article-title":"The novel T107I inherited prion disease can present as a clinical and biomarker mimic of familial Alzheimer's disease","volume":"39","author":"Holm-Mercer","year":"2025","journal-title":"J Neurogenet"},{"key":"10.1016\/S1474-4422(25)00451-X_bib27","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.14309\/ajg.0000000000001044","article-title":"Prion gene PRNP Y162X truncation mutation can induce a refractory esophageal achalasia","volume":"116","author":"Matsuzono","year":"2021","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/S1474-4422(25)00451-X_bib28","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1056\/NEJMoa1214747","article-title":"A novel prion disease associated with diarrhea and autonomic neuropathy","volume":"369","author":"Mead","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/S1474-4422(25)00451-X_bib29","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1002\/acn3.568","article-title":"Two novel PRNP truncating mutations broaden the spectrum of prion amyloidosis","volume":"5","author":"Capellari","year":"2018","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/S1474-4422(25)00451-X_bib30","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1111\/ene.12089","article-title":"A novel familial prion disease causing pan-autonomic-sensory neuropathy and cognitive impairment","volume":"20","author":"Matsuzono","year":"2013","journal-title":"Eur J Neurol"},{"key":"10.1016\/S1474-4422(25)00451-X_bib31","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s12035-020-02098-8","article-title":"Characterization of anchorless human PrP with Q227X stop mutation linked to Gerstmann\u2013Str\u00e4ussler\u2013Scheinker syndrome in vivo and in vitro","volume":"58","author":"Shen","year":"2021","journal-title":"Mol Neurobiol"},{"key":"10.1016\/S1474-4422(25)00451-X_bib32","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s00401-009-0609-x","article-title":"Prion protein amyloidosis with divergent phenotype associated with two novel nonsense mutations in PRNP","volume":"119","author":"Jansen","year":"2010","journal-title":"Acta Neuropathol"},{"key":"10.1016\/S1474-4422(25)00451-X_bib33","doi-asserted-by":"crossref","first-page":"322ra9","DOI":"10.1126\/scitranslmed.aad5169","article-title":"Quantifying prion disease penetrance using large population control cohorts","volume":"8","author":"Minikel","year":"2016","journal-title":"Sci Transl Med"},{"key":"10.1016\/S1474-4422(25)00451-X_bib34","doi-asserted-by":"crossref","first-page":"e125","DOI":"10.1212\/WNL.0000000000007745","article-title":"Age at onset in genetic prion disease and the design of preventive clinical trials","volume":"93","author":"Minikel","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/S1474-4422(25)00451-X_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3000725","article-title":"Spontaneous generation of prions and transmissible PrP amyloid in a humanised transgenic mouse model of A117V GSS","volume":"18","author":"Asante","year":"2020","journal-title":"PLoS Biol"},{"key":"10.1016\/S1474-4422(25)00451-X_bib36","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s00439-005-0020-1","article-title":"Genetic prion disease: the EUROCJD experience","volume":"118","author":"Kov\u00e1cs","year":"2005","journal-title":"Hum Genet"},{"key":"10.1016\/S1474-4422(25)00451-X_bib37","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1007\/s12264-021-00764-y","article-title":"Genetic prion disease: insight from the features and experience of China National Surveillance for Creutzfeldt\u2013Jakob disease","volume":"37","author":"Shi","year":"2021","journal-title":"Neurosci Bull"},{"key":"10.1016\/S1474-4422(25)00451-X_bib38","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1093\/brain\/awq216","article-title":"Prospective 10-year surveillance of human prion diseases in Japan","volume":"133","author":"Nozaki","year":"2010","journal-title":"Brain"},{"key":"10.1016\/S1474-4422(25)00451-X_bib39","doi-asserted-by":"crossref","first-page":"625","DOI":"10.3390\/ijms24010625","article-title":"Prion mutations in Republic of Korea, China, and Japan","volume":"24","author":"Kim","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/S1474-4422(25)00451-X_bib40","article-title":"Updated global epidemiology atlas of human prion diseases","volume":"12","author":"Gao","year":"2024","journal-title":"Front Public Health"},{"key":"10.1016\/S1474-4422(25)00451-X_bib41","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.3201\/eid2809.212050","article-title":"Creutzfeldt\u2013Jakob disease incidence, South Korea, 2001\u20132019","volume":"28","author":"Kim","year":"2022","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/S1474-4422(25)00451-X_bib42","doi-asserted-by":"crossref","first-page":"265.e1","DOI":"10.1016\/j.neurobiolaging.2018.05.011","article-title":"Evaluating the causality of novel sequence variants in the prion protein gene by example","volume":"71","author":"Mok","year":"2018","journal-title":"Neurobiol Aging"},{"key":"10.1016\/S1474-4422(25)00451-X_bib43","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1038\/s41431-022-01132-8","article-title":"Estimation of the number of inherited prion disease mutation carriers in the UK","volume":"30","author":"Corbie","year":"2022","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/S1474-4422(25)00451-X_bib44","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232315172","article-title":"Systematic review of clinical and pathophysiological features of genetic Creutzfeldt\u2013Jakob disease caused by a Val-to-Ile mutation at codon 180 in the prion protein gene","volume":"23","author":"Matsubayashi","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/S1474-4422(25)00451-X_bib45","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1186\/s12883-021-02274-w","article-title":"Case report of homozygous E200D mutation of PRNP in apparently sporadic Creutzfeldt\u2013Jakob disease","volume":"21","author":"Hassan","year":"2021","journal-title":"BMC Neurol"},{"key":"10.1016\/S1474-4422(25)00451-X_bib46","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/s13195-021-00912-6","article-title":"Homozygous R136S mutation in PRNP gene causes inherited early onset prion disease","volume":"13","author":"Ximelis","year":"2021","journal-title":"Alzheimers Res Ther"},{"key":"10.1016\/S1474-4422(25)00451-X_bib47","doi-asserted-by":"crossref","first-page":"E1551","DOI":"10.1002\/humu.21281","article-title":"PRNP allelic series from 19 years of prion protein gene sequencing at the MRC Prion Unit","volume":"31","author":"Beck","year":"2010","journal-title":"Hum Mutat"},{"key":"10.1016\/S1474-4422(25)00451-X_bib48","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/1531-8249(200002)47:2<257::AID-ANA20>3.0.CO;2-U","article-title":"Creutzfeldt\u2013Jakob disease profile in patients homozygous for the PRNP E200K mutation","volume":"47","author":"Simon","year":"2000","journal-title":"Ann Neurol"},{"key":"10.1016\/S1474-4422(25)00451-X_bib49","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1136\/jnnp-2017-316853","article-title":"Imaging and CSF analyses effectively distinguish CJD from its mimics","volume":"89","author":"Rudge","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/S1474-4422(25)00451-X_bib50","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1136\/practneurol-2016-001571","article-title":"CJD mimics and chameleons","volume":"17","author":"Mead","year":"2017","journal-title":"Pract Neurol"},{"key":"10.1016\/S1474-4422(25)00451-X_bib51","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/s41582-022-00659-0","article-title":"Rapidly progressive dementias \u2013 aetiologies, diagnosis and management","volume":"18","author":"Hermann","year":"2022","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/S1474-4422(25)00451-X_bib52","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1093\/brain\/awab350","article-title":"Diagnostic accuracy of cerebrospinal fluid biomarkers in genetic prion diseases","volume":"145","author":"Schmitz","year":"2022","journal-title":"Brain"},{"key":"10.1016\/S1474-4422(25)00451-X_bib53","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/mdc3.13976","article-title":"Gerstmann\u2013Str\u00e4ussler\u2013Scheinker disease presenting as late-onset slowly progressive spinocerebellar ataxia, and comparative case series with neuropathology","volume":"11","author":"Stephen","year":"2024","journal-title":"Mov Disord Clin Pract"},{"key":"10.1016\/S1474-4422(25)00451-X_bib54","doi-asserted-by":"crossref","first-page":"3419","DOI":"10.1007\/s10072-022-05927-x","article-title":"First familial cases of P102L Gerstmann\u2013Str\u00e4ussler\u2013Scheinker syndrome in South Korea: diffusion-weighted imaging might reflect intrafamilial phenotypic variability","volume":"43","author":"Ahn","year":"2022","journal-title":"Neurol Sci"},{"key":"10.1016\/S1474-4422(25)00451-X_bib55","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1212\/WNL.0000000000201321","article-title":"Pearls and oy-sters: deep phenotyping of abnormal eye movements advances the detection of Gerstmann\u2013Str\u00e4ussler\u2013Scheinker syndrome","volume":"99","author":"Paul","year":"2022","journal-title":"Neurology"},{"key":"10.1016\/S1474-4422(25)00451-X_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2024.123166","article-title":"Involvement of the nigrostriatal system in Gerstman\u2013Str\u00e4ussler\u2013Scheinker disease with the PRNP-P102L mutation","volume":"464","author":"Ono","year":"2024","journal-title":"J Neurol Sci"},{"key":"10.1016\/S1474-4422(25)00451-X_bib57","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000025687","article-title":"Gerstmann\u2013Str\u00e4ussler\u2013Scheinker syndrome misdiagnosed as cervical spondylotic myelopathy: a case report with 5-year follow-up","volume":"100","author":"Cao","year":"2021","journal-title":"Medicine"},{"key":"10.1016\/S1474-4422(25)00451-X_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.parkreldis.2023.105332","article-title":"From parasomnia to agrypnia excitata \u2013 an illustrative case on diagnostic approach","volume":"109","author":"Fong","year":"2023","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/S1474-4422(25)00451-X_bib59","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.sleep.2022.02.010","article-title":"Postural instability and backward leaning in a patient of familial fatal insomnia with positive SOX1 antibodies","volume":"91","author":"Gong","year":"2022","journal-title":"Sleep Med"},{"key":"10.1016\/S1474-4422(25)00451-X_bib60","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1186\/s12883-024-03999-0","article-title":"A fatal familial insomnia patient initially misdiagnosed as Alzheimer's disease: a case report","volume":"24","author":"Qiao","year":"2024","journal-title":"BMC Neurol"},{"key":"10.1016\/S1474-4422(25)00451-X_bib61","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1080\/19336896.2020.1812367","article-title":"Corticobasal manifestations of Creutzfeldt\u2013Jakob disease with D178N-homozygous 129M genotype","volume":"14","author":"Huang","year":"2020","journal-title":"Prion"},{"key":"10.1016\/S1474-4422(25)00451-X_bib62","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1093\/jnen\/nlac113","article-title":"Analysis of a large case series of fatal familial insomnia to determine tests with the highest diagnostic value","volume":"82","author":"Kortazar-Zubizarreta","year":"2023","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/S1474-4422(25)00451-X_bib63","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.sleep.2022.08.027","article-title":"Sleep architecture and sleep-disordered breathing in fatal insomnia","volume":"100","author":"P\u00e9rez-Carbonell","year":"2022","journal-title":"Sleep Med"},{"key":"10.1016\/S1474-4422(25)00451-X_bib64","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1080\/19336896.2023.2180255","article-title":"A family with mental disorder as the first symptom finally confirmed with Gerstmann\u2013Str\u00e4ussler\u2013Scheinker disease with P102L mutation in PRNP gene \u2013 case report","volume":"17","author":"Chen","year":"2023","journal-title":"Prion"},{"key":"10.1016\/S1474-4422(25)00451-X_bib65","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41582-020-00416-1","article-title":"Genetic testing in dementia\u2014utility and clinical strategies","volume":"17","author":"Koriath","year":"2021","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/S1474-4422(25)00451-X_bib66","doi-asserted-by":"crossref","first-page":"3399","DOI":"10.1038\/s41380-018-0224-0","article-title":"Predictors for a dementia gene mutation based on gene-panel next-generation sequencing of a large dementia referral series","volume":"25","author":"Koriath","year":"2020","journal-title":"Mol Psychiatry"},{"key":"10.1016\/S1474-4422(25)00451-X_bib67","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/ene.14559","article-title":"An unusual familial dementia associated with G131V PRNP mutation","volume":"28","author":"Yetim","year":"2021","journal-title":"Eur J Neurol"},{"key":"10.1016\/S1474-4422(25)00451-X_bib68","doi-asserted-by":"crossref","first-page":"e1017","DOI":"10.1212\/WNL.0000000000010086","article-title":"Diagnosis of prion diseases by RT-QuIC results in improved surveillance","volume":"95","author":"Rhoads","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/S1474-4422(25)00451-X_bib69","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0054915","article-title":"Early detection of abnormal prion protein in genetic human prion diseases now possible using real-time QUIC assay","volume":"8","author":"Sano","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/S1474-4422(25)00451-X_bib70","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1001\/jamaneurol.2016.4614","article-title":"Diagnosis of human prion disease using real-time quaking-induced conversion testing of olfactory mucosa and cerebrospinal fluid samples","volume":"74","author":"Bongianni","year":"2017","journal-title":"JAMA Neurol"},{"key":"10.1016\/S1474-4422(25)00451-X_bib71","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/j.gim.2022.06.003","article-title":"Genetic counseling for prion disease: updates and best practices","volume":"24","author":"Goldman","year":"2022","journal-title":"Genet Med"},{"key":"10.1016\/S1474-4422(25)00451-X_bib72","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/ajmg.b.32505","article-title":"Genetic prion disease: experience of a rapidly progressive dementia center in the United States and a review of the literature","volume":"174","author":"Takada","year":"2017","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"10.1016\/S1474-4422(25)00451-X_bib73","doi-asserted-by":"crossref","first-page":"895","DOI":"10.3389\/fgene.2019.00895","article-title":"Genetic testing in prion disease: psychological consequences of the decisions to know or not to know","volume":"10","author":"Schwartz","year":"2019","journal-title":"Front Genet"},{"key":"10.1016\/S1474-4422(25)00451-X_bib74","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1002\/mds.29152","article-title":"Prevalence and treatments of movement disorders in prion diseases: a longitudinal cohort study","volume":"37","author":"Sequeira","year":"2022","journal-title":"Mov Disord"},{"key":"10.1016\/S1474-4422(25)00451-X_bib75","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1176\/appi.ajp.2013.12111460","article-title":"Behavioral and psychiatric symptoms in prion disease","volume":"171","author":"Thompson","year":"2014","journal-title":"Am J Psychiatry"},{"key":"10.1016\/S1474-4422(25)00451-X_bib76","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph18189734","article-title":"Swallowing function evaluation in a patient with Gerstmann\u2013Str\u00e4ussler\u2013Scheinker disease with Pro105Leu: a case report","volume":"18","author":"Nakane","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/S1474-4422(25)00451-X_bib78","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1002\/ana.410430618","article-title":"Codon 219 Lys allele of PRNP is not found in sporadic Creutzfeldt\u2013Jakob disease","volume":"43","author":"Shibuya","year":"1998","journal-title":"Ann Neurol"},{"key":"10.1016\/S1474-4422(25)00451-X_bib79","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s00401-023-02553-5","article-title":"A point mutation in GPI-attachment signal peptide accelerates the development of prion disease","volume":"145","author":"Kobayashi","year":"2023","journal-title":"Acta Neuropathol"},{"key":"10.1016\/S1474-4422(25)00451-X_bib80","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1056\/NEJMc1610003","article-title":"Variant Creutzfeldt\u2013Jakob disease in a patient with heterozygosity at PRNP codon 129","volume":"376","author":"Mok","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/S1474-4422(25)00451-X_bib81","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1126\/science.1083320","article-title":"Balancing selection at the prion protein gene consistent with prehistoric kurulike epidemics","volume":"300","author":"Mead","year":"2003","journal-title":"Science"},{"key":"10.1016\/S1474-4422(25)00451-X_bib82","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1056\/NEJMoa0809716","article-title":"A novel protective prion protein variant that colocalizes with kuru exposure","volume":"361","author":"Mead","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/S1474-4422(25)00451-X_bib83","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/nature14510","article-title":"A naturally occurring variant of the human prion protein completely prevents prion disease","volume":"522","author":"Asante","year":"2015","journal-title":"Nature"},{"key":"10.1016\/S1474-4422(25)00451-X_bib84","doi-asserted-by":"crossref","first-page":"3386","DOI":"10.1093\/brain\/awv235","article-title":"Iatrogenic CJD due to pituitary-derived growth hormone with genetically determined incubation times of up to 40 years","volume":"138","author":"Rudge","year":"2015","journal-title":"Brain"},{"key":"10.1016\/S1474-4422(25)00451-X_bib85","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.neurobiolaging.2007.07.014","article-title":"Increased frequency of positive family history of dementia in sporadic CJD","volume":"30","author":"Krasnianski","year":"2009","journal-title":"Neurobiol Aging"},{"key":"10.1016\/S1474-4422(25)00451-X_bib86","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/ana.22094","article-title":"Variably protease-sensitive prionopathy: a new sporadic disease of the prion protein","volume":"68","author":"Zou","year":"2010","journal-title":"Ann Neurol"},{"key":"10.1016\/S1474-4422(25)00451-X_bib87","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1013343","article-title":"Search for a genetic cause of variably protease-sensitive prionopathy","volume":"21","author":"Lian","year":"2025","journal-title":"PLoS Pathog"},{"key":"10.1016\/S1474-4422(25)00451-X_bib88","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/S1474-4422(20)30273-8","article-title":"Identification of novel risk loci and causal insights for sporadic Creutzfeldt\u2013Jakob disease: a genome-wide association study","volume":"19","author":"Jones","year":"2020","journal-title":"Lancet Neurol"},{"key":"10.1016\/S1474-4422(25)00451-X_bib89","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2023.106363","article-title":"Characterisation and prion transmission study in mice with genetic reduction of sporadic Creutzfeldt\u2013Jakob disease risk gene Stx6","volume":"190","author":"Jones","year":"2024","journal-title":"Neurobiol Dis"},{"key":"10.1016\/S1474-4422(25)00451-X_bib90","doi-asserted-by":"crossref","first-page":"3350","DOI":"10.1093\/brain\/awaf032","article-title":"Multiomic analyses direct hypotheses for Creutzfeldt\u2013Jakob disease risk genes","volume":"148","author":"K\u00fc\u00e7\u00fckali","year":"2025","journal-title":"Brain"},{"key":"10.1016\/S1474-4422(25)00451-X_bib91","doi-asserted-by":"crossref","DOI":"10.3390\/cells12162053","article-title":"Genetic variants associated with the age of onset identified by whole-exome sequencing in fatal familial insomnia","volume":"12","author":"Th\u00fcne","year":"2023","journal-title":"Cells"},{"key":"10.1016\/S1474-4422(25)00451-X_bib92","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1136\/jnnp-2018-318756","article-title":"Age at onset of genetic (E200K) and sporadic Creutzfeldt\u2013Jakob diseases is modulated by the CYP4X1 gene","volume":"89","author":"Poleggi","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/S1474-4422(25)00451-X_bib93","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s00401-021-02350-y","article-title":"Phenotypic diversity of genetic Creutzfeldt\u2013Jakob disease: a histo-molecular-based classification","volume":"142","author":"Baiardi","year":"2021","journal-title":"Acta Neuropathol"},{"key":"10.1016\/S1474-4422(25)00451-X_bib94","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/bpa.12695","article-title":"Recent advances in the histo-molecular pathology of human prion disease","volume":"29","author":"Baiardi","year":"2019","journal-title":"Brain Pathol"},{"key":"10.1016\/S1474-4422(25)00451-X_bib95","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/B978-0-444-63945-5.00014-3","article-title":"Dominantly inherited prion protein cerebral amyloidoses \u2013 a modern view of Gerstmann\u2013Str\u00e4ussler\u2013Scheinker","volume":"153","author":"Ghetti","year":"2018","journal-title":"Handb Clin Neurol"},{"key":"10.1016\/S1474-4422(25)00451-X_bib96","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/1531-8249(199908)46:2<224::AID-ANA12>3.0.CO;2-W","article-title":"Classification of sporadic Creutzfeldt\u2013Jakob disease based on molecular and phenotypic analysis of 300 subjects","volume":"46","author":"Parchi","year":"1999","journal-title":"Ann Neurol"},{"key":"10.1016\/S1474-4422(25)00451-X_bib97","doi-asserted-by":"crossref","first-page":"3258","DOI":"10.1021\/bi982714g","article-title":"Influence of amino acid substitutions related to inherited human prion diseases on the thermodynamic stability of the cellular prion protein","volume":"38","author":"Liemann","year":"1999","journal-title":"Biochemistry"},{"key":"10.1016\/S1474-4422(25)00451-X_bib98","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s00401-022-02461-0","article-title":"Cryo-EM structures of prion protein filaments from Gerstmann\u2013Str\u00e4ussler\u2013Scheinker disease","volume":"144","author":"Hallinan","year":"2022","journal-title":"Acta Neuropathol"},{"key":"10.1016\/S1474-4422(25)00451-X_bib99","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/bs.pmbts.2020.08.007","article-title":"Transgenic mouse models for the study of prion diseases","volume":"175","author":"Mar\u00edn-Moreno","year":"2020","journal-title":"Prog Mol Biol Transl Sci"},{"key":"10.1016\/S1474-4422(25)00451-X_bib100","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.neurobiolaging.2023.07.024","article-title":"Spontaneous prion disease in homozygous and heterozygous transgenic mouse models of T188K genetic Creutzfeldt\u2013Jakob disease","volume":"131","author":"Wu","year":"2023","journal-title":"Neurobiol Aging"},{"key":"10.1016\/S1474-4422(25)00451-X_bib101","doi-asserted-by":"crossref","DOI":"10.1172\/JCI176344","article-title":"Convergent generation of atypical prions in knockin mouse models of genetic prion disease","volume":"134","author":"Mehra","year":"2024","journal-title":"J Clin Invest"},{"key":"10.1016\/S1474-4422(25)00451-X_bib102","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1093\/brain\/awab152","article-title":"An in vivo Caenorhabditis elegans model for therapeutic research in human prion diseases","volume":"144","author":"Bizat","year":"2021","journal-title":"Brain"},{"key":"10.1016\/S1474-4422(25)00451-X_bib103","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1016\/j.stemcr.2024.08.010","article-title":"Abnormal synaptic architecture in iPSC-derived neurons from a multi-generational family with genetic Creutzfeldt\u2013Jakob disease","volume":"19","author":"Gojanovich","year":"2024","journal-title":"Stem Cell Reports"},{"key":"10.1016\/S1474-4422(25)00451-X_bib104","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1010565","article-title":"Altered energy metabolism in fatal familial insomnia cerebral organoids is associated with astrogliosis and neuronal dysfunction","volume":"19","author":"Foliaki","year":"2023","journal-title":"PLoS Genet"},{"key":"10.1016\/S1474-4422(25)00451-X_bib105","doi-asserted-by":"crossref","first-page":"482","DOI":"10.3390\/pathogens9060482","article-title":"Pathogenic prion protein isoforms are not present in cerebral organoids generated from asymptomatic donors carrying the E200K mutation associated with familial prion disease","volume":"9","author":"Foliaki","year":"2020","journal-title":"Pathogens"},{"key":"10.1016\/S1474-4422(25)00451-X_bib106","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/S1474-4422(22)00082-5","article-title":"Prion protein monoclonal antibody (PRN100) therapy for Creutzfeldt\u2013Jakob disease: evaluation of a first-in-human treatment programme","volume":"21","author":"Mead","year":"2022","journal-title":"Lancet Neurol"},{"key":"10.1016\/S1474-4422(25)00451-X_bib107","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/nature01457","article-title":"Monoclonal antibodies inhibit prion replication and delay the development of prion disease","volume":"422","author":"White","year":"2003","journal-title":"Nature"},{"key":"10.1016\/S1474-4422(25)00451-X_bib108","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1099\/vir.0.83578-0","article-title":"Effect of intraventricular infusion of anti-prion protein monoclonal antibodies on disease progression in prion-infected mice","volume":"89","author":"Song","year":"2008","journal-title":"J Gen Virol"},{"key":"10.1016\/S1474-4422(25)00451-X_bib109","doi-asserted-by":"crossref","first-page":"10615","DOI":"10.1093\/nar\/gkaa616","article-title":"Prion protein lowering is a disease-modifying therapy across prion disease stages, strains and endpoints","volume":"48","author":"Minikel","year":"2020","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/S1474-4422(25)00451-X_bib110","article-title":"Divalent siRNA for prion disease","author":"Gentile","year":"2025","journal-title":"bioRxiv"},{"key":"10.1016\/S1474-4422(25)00451-X_bib111","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1038\/s41591-024-03466-w","article-title":"In vivo base editing extends lifespan of a humanized mouse model of prion disease","volume":"31","author":"An","year":"2025","journal-title":"Nat Med"},{"key":"10.1016\/S1474-4422(25)00451-X_bib112","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0002773","article-title":"Effective gene therapy in a mouse model of prion diseases","volume":"3","author":"Toupet","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/S1474-4422(25)00451-X_bib113","article-title":"Zinc Finger Repressors mediate widespread PRNP lowering in the nonhuman primate brain and profoundly extend survival in prion disease mice","author":"Chou","year":"2025","journal-title":"bioRxiv"},{"key":"10.1016\/S1474-4422(25)00451-X_bib114","doi-asserted-by":"crossref","DOI":"10.1126\/science.ado7082","article-title":"Brainwide silencing of prion protein by AAV-mediated delivery of an engineered compact epigenetic editor","volume":"384","author":"Neumann","year":"2024","journal-title":"Science"},{"key":"10.1016\/S1474-4422(25)00451-X_bib115","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1126\/science.adp3043","article-title":"Foiling deadly prions","volume":"383","author":"Wadman","year":"2024","journal-title":"Science"},{"key":"10.1016\/S1474-4422(25)00451-X_bib116","article-title":"Antisense oligonucleotides extend survival of prion-infected mice","volume":"5","author":"Raymond","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/S1474-4422(25)00451-X_bib117","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S1474-4422(19)30403-X","article-title":"Towards a treatment for genetic prion disease: trials and biomarkers","volume":"19","author":"Vallabh","year":"2020","journal-title":"Lancet Neurol"},{"key":"10.1016\/S1474-4422(25)00451-X_bib118","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1080\/19336896.2022.2083435","article-title":"Preventive pharmacological treatment in subjects at risk for fatal familial insomnia: science and public engagement","volume":"16","author":"Forloni","year":"2022","journal-title":"Prion"},{"key":"10.1016\/S1474-4422(25)00451-X_bib119","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000209506","article-title":"Fluid biomarkers in individuals at risk for genetic prion disease up to disease conversion","volume":"103","author":"Vallabh","year":"2024","journal-title":"Neurology"},{"key":"10.1016\/S1474-4422(25)00451-X_bib120","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1093\/brain\/awad101","article-title":"Seed amplification and neurodegeneration marker trajectories in individuals at risk of prion disease","volume":"146","author":"Mok","year":"2023","journal-title":"Brain"},{"key":"10.1016\/S1474-4422(25)00451-X_bib121","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S1474-4422(25)00406-5","article-title":"Advances in biomarkers for diagnosis and prognosis of prion diseases","volume":"25","author":"Zerr","year":"2026","journal-title":"Lancet Neurol"},{"key":"10.1016\/S1474-4422(25)00451-X_bib122","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.3233\/JAD-200576","article-title":"Metabolic changes detected by 18F-FDG PET in the preclinical stage of familial Creutzfeldt\u2013Jakob disease","volume":"77","author":"Lu","year":"2020","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/S1474-4422(25)00451-X_bib123","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1093\/brain\/awaa409","article-title":"Cognitive decline heralds onset of symptomatic inherited prion disease","volume":"144","author":"Mole","year":"2021","journal-title":"Brain"}],"container-title":["The Lancet Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147444222500451X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147444222500451X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T20:27:22Z","timestamp":1779827242000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S147444222500451X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":122,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S147444222500451X"],"URL":"https:\/\/doi.org\/10.1016\/s1474-4422(25)00451-x","relation":{},"ISSN":["1474-4422"],"issn-type":[{"value":"1474-4422","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic causes and modifiers of prion diseases","name":"articletitle","label":"Article Title"},{"value":"The Lancet Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S1474-4422(25)00451-X","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S1474-4422(26)00001-3","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/S1474-4422(25)00406-5","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}